PDF-2Restoration courtesy of Al Hodges CDT DTG

INTRODUCING ceramic for Lithium Disilicate substructures For the 31rst time ever Initial LiSi offers the highest more cost effective option for your most popular restorationslithium disilicate f. Jim Demarest. ,. 1. Mark Underwood,. 2. Marty St Clair,. 2. . David Dorey,. 3. Steve Almond,. 3. Robert Cuffe,. 4. . Dannae Brown,. 5. Garrett Nichols. 6. . 1. ViiV Healthcare, Global R&D, Research Triangle Park, NC, USA; . FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . Design. Objective. Non inferiority of DTG at W48: % HIV RNA < 50 c/mL by intention to treat, snapshot analysis (1-sided significance level of 2.5%, lower margin of the 95% CI for the difference = -12%, 90% power). STRIIVING . Study. Design. Endpoints. Primary: proportion of patients maintaining HIV RNA < 50 c/mL at W48 . (ITT-E, snapshot) ; non-inferiority if lower margin of the two-sided 95% CI . for the difference = - 10%, 90% power . 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Compared With Lopinavir/Ritonavir (LPV/RTV) Plus . 2 NRTIs in Second-Line Treatment: Interim Data From the DAWNING Study. Michael Aboud,. 1. Richard Kaplan,. and 22. nd. International AIDS Conference . Selected Pediatric, PMTCT, . and Maternal/Adult. Abstracts. Lynne Mofenson MD 08/06/2018. webinar version. Main Subject - . Everything Dolutegravir. Studies in HIV-Infected Adults/Adolescents. November 13, 2014. Monica Rho, . MD. Assistant Professor. Director of Women’s Sports Medicine Program . Spine & Sports Rehabilitation. Rehabilitation Institute of Chicago. Northwestern . University Feinberg School of Medicine. dolutegravir. at the time of conception. Meg Doherty, MD, MPH, PhD. WHO Geneva. 22 . J. uly 2018. www.iasociety.org/HIV-Programmes/Campaigns/Generation-Now. 2017. Globally. 36.9 million. People living with HIV. 1 Queen Mary University, London, United Kingdom; 2 EPIMED GmbH, Berlin, Germany; 3 Hospital Universitario Fundación Jiménez Díaz , Madrid, Spain; 4 Central Institute of Epidemiology, Moscow, Russian Federation; sleep disturbances in children and adolescents randomised to. dolutegravir-based ART vs standard-of-care in the ODYSSEY trial. PRESENTED AT IAS 2021 – the 11th IAS Conference on HIV Science. |18-21 JULY 2021. The Benefits of Reading Books Endpoints. Primary: proportion of patients with HIV RNA ≥ 50 c/mL at W48 (ITT-E, snapshot) ; non-inferiority if upper margin of the two-sided 95% CI for the difference = 4%, 97.3% power . Secondary: proportion of patients with HIV RNA < 50 c/mL at W48 (ITT-E, snapshot) ; non-inferiority if lower margin of the two-sided 95% CI for the difference = - 8%. by Baseline NRTI Resistance . and Second-Line NRTI Use. Dannae. Brown,. 1. . Ruolan. Wang,. 2. Mark Underwood,. 2. Judy Hopking,. 3. Maria Claudia Nascimento,. 4. . Michael Aboud,. 4. . Jörg. 1. ViiV Healthcare, Brentford, UK; . 2. Centre Hospitalier de Tourcoing, Tourcoing, France; . 3. Holdsworth House Medical Brisbane, Queensland, Australia; . 4. CHU Saint-Pierre, Brussels, Belgium; . 5. ADVANCE. . Design. Primary endpoint. Proportion of patients with HIV RNA < 50 c/mL at W48, ITT-E snapshot analysis ; non-inferiority of TFA/FTC if lower margin CI for . the difference = - 10%, 80% power.